- Dyadic Announces Change in Board and Management Leadership Roles
- Dyadic to Attend Industry Events in April
- Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
- Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
- Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
- CORRECTION – Dyadic Announces Closing of Private Placement of $6.0 Million Convertible Notes to Accelerate Near-Term Revenue Growth and Commercialization
- Dyadic to Attend Industry Events in March
- Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform
- Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
- Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
More ▼
Key statistics
On Friday, Dyadic International Inc (DYAI:NAQ) closed at 1.49, 25.21% above the 52 week low of 1.19 set on Jan 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.60 |
---|---|
High | 1.60 |
Low | 1.43 |
Bid | 1.20 |
Offer | 2.00 |
Previous close | 1.49 |
Average volume | 13.58k |
---|---|
Shares outstanding | 28.97m |
Free float | 20.03m |
P/E (TTM) | -- |
Market cap | 43.17m USD |
EPS (TTM) | -0.2359 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 20:59 BST.
More ▼